Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

Bruno Dubois(Portland State University), Cliff R Jack(Mayo Clinic in Arizona), Hovagim Bakardjian(Institut de Psychiatrie et Neurosciences de Paris), Lars Bertram(Universitat Internacional de Catalunya), Serge Gauthier(Texas Instruments (France)), Christopher C. Rowe(The University of Melbourne), Kaj Blennow(Sahlgrenska University Hospital), Philip Scheltens(Amsterdam University Medical Centers), Miia Kivipelto(Karolinska University Hospital), María C. Carrillo(Brigham and Women's Hospital), Marie‐Odile Habert(Centre National de la Recherche Scientifique), José Luís Molinuevo(Pasqual Maragall Foundation), Harald Hampel(Sorbonne Université), Sebastian J. Crutch(NIHR Queen Square Dementia Biomedical Research Unit), Charles Duyckaerts(Centre National de la Recherche Scientifique), Howard Feldman(University of British Columbia), Jean‐François Dartigues(Université de Bordeaux), Giovanni B. Frisoni(University of Geneva), Karl Broich(Federal Institute for Drugs and Medical Devices), Gil D. Rabinovici(University of California, San Francisco), Lon S. Schneider(University of Southern California), Sid E. O’Bryant(University of North Texas), Jeffrey L. Cummings(University of California, Los Angeles), Marc Teichmann(Sorbonne Université), Alida A. Gouw(Amsterdam Neuroscience), Simone Lista(Universidad Europea Miguel de Cervantes), Enrica Cavedo(Centro San Giovanni di Dio Fatebenefratelli), David M. Holtzman(Hope Center for Neurological Disorders), Habib Benali(Centre National de la Recherche Scientifique), Stéphane Epelbaum(Washington University in St. Louis), Sandrine Andrieu(Université Toulouse III - Paul Sabatier), Paul Aisen(University of Southern California), Reisa A. Sperling(Harvard University), Rémy Genthon, Stephen Salloway(Providence College)
Alzheimer s & Dementia
March 1, 2016
Cited by 1,911


Related Papers